Keyphrases
Non-small Cell Lung Cancer (NSCLC)
66%
Oligoprogressive Disease
50%
Lung Cancer
50%
Cachexia
50%
Sarcopenia
50%
Oligometastatic
50%
Oligoprogressive
50%
Radical Treatment
21%
Oligometastatic Disease
19%
Oncogene-driven
16%
Treatment Modalities
16%
EORTC
11%
Number of Metastases
10%
Ongoing Clinical Trials
8%
Metastatic Spread
8%
Improved Survival
8%
Ongoing Trials
8%
Tumor Biology
8%
Subclassification
8%
Management Strategy
8%
ESTRO
8%
ASTRO
8%
Disease Heterogeneity
8%
Diagnostic Modalities
8%
Metastatic NSCLC
8%
Tailored Management
8%
Individualized Treatment
8%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
7%
Survival Outcomes
7%
INIS
diseases
100%
cancer
100%
immunotherapy
50%
patients
50%
lungs
50%
lung cells
50%
metastases
26%
comparative evaluations
17%
oncogenes
16%
management
16%
biology
8%
tumors
8%
clinical trials
8%
reviews
8%
risks
8%
Medicine and Dentistry
Disease
100%
Non Small Cell Lung Cancer
50%
Lung Cancer
50%
Cachexia
50%
Sarcopenia
50%
Immunotherapy
50%
Non-Small Cell Lung Cancer
25%
Oncogene
16%
Metastatic Carcinoma
14%
Clinical Trial
8%
Tumor Biology
8%
Diagnosis
8%
Clinician
7%
